Reagents
Ended Awarded Last action
- Contract number
- 36C24925N0151
- Awardee
-
Roche Diagnostics Corporation UEI JDMDFEZBYH36
- Awarding agency
-
Veterans Integrated Service Network 9
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $244,820
Award facts
- Contract value 100% obligated
- $244,820.10 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- No set-aside
- Competition
- Not Competed Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- Dublin, OH 43017, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$20,589 | |
| Funding Only Action | $40,000 | |
| Original award | $225,410 |
About this award
This delivery order modification was issued to Roche Diagnostics Corporation on October 1, 2024, to close out and de-obligate excess funds from a Fiscal Year 2025 reagents order. The contract, valued at $244,820.10 under a Firm Fixed Price arrangement, supports the Veterans Integrated Service Network 9 (VISN 9) within the Department of Veterans Affairs. The work is performed in Dublin, Ohio, and involves the supply of diagnostic reagents and related materials. No set-aside designation was applied to this award, allowing Roche Diagnostics to compete openly in the federal marketplace. This modification represents a child contract under a larger procurement vehicle, likely one of Roche's established Blanket Purchase Agreements or Indefinite Delivery Contracts with the VA.
Roche Diagnostics Corporation is a global manufacturer of in vitro diagnostic products, reagents, laboratory instruments, and clinical testing services that support the VA's medical diagnostic capabilities across its integrated service networks. The company holds significant contract relationships with the Department of Veterans Affairs and other federal healthcare agencies, providing comprehensive laboratory solutions including molecular diagnostic testing, clinical chemistry analysis, immunochemistry testing, and specialized reagents. The modification to close and de-obligate funds indicates a reconciliation of the original obligation to align actual spending requirements, ensuring proper stewardship of federal healthcare resources allocated to diagnostic support services for the veteran population served by VISN 9.
Quick answers
Who was awarded contract 36C24925N0151?
36C24925N0151 was awarded to Roche Diagnostics Corporation by Veterans Integrated Service Network 9 (Veterans Health Administration) on October 1, 2024.
How much is contract 36C24925N0151 worth?
The government has obligated $244,820 on 36C24925N0151.
Is contract 36C24925N0151 an order under another contract?
Yes. 36C24925N0151 is a delivery order under 36C24925D0025, an indefinite delivery contract.
Was contract 36C24925N0151 competed?
The extent of competition for 36C24925N0151 was not competed.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award